Medicine guide

Rivaroxaban vascular Spirig HC 2.5 mg

As listed in the register: Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten

2.5 mg ·

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Rivaroxabanum
Made by
Spirig HealthCare AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • In Kombination mit Acetylsalicylsäure zur Prävention schwerwiegender atherothrombotischer Ereignisse bei Patienten mit koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made bySpirig HealthCare AG
Active substanceRivaroxabanum
Used inBlood, clotting and anaemia
Strength2.5 mg
ClassificationB01AF01 · Blood, clotting and anaemia
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerRivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten
Packs56 Tablette(n) · 196 Tablette(n)
Zulassungsnummer68551
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.